Skip to main content

Animals production of vaccine and pharmaceuticals, hybridomas, monoclonal antibodies.


Animals in the Production of Vaccines and Pharmaceuticals – Hybridomas and Monoclonal antibodies

Introduction

Animals have played a crucial role in the production of vaccines and pharmaceutical products. They serve as biological systems for the synthesis of complex proteins, antibodies, hormones, enzymes, and vaccines. Animal-based production is especially important when post-translational modifications are required. Hybridoma technology and monoclonal antibodies represent major breakthroughs in medical biotechnology.

Animals in the Production of Vaccines
Role of Animals

Animals are used:
As hosts for propagation of pathogens
For testing vaccine safety and efficacy
For large-scale production of antigens
Types of Vaccines Produced Using Animals

Live attenuated vaccines
Example: Rabies vaccine (grown in chick embryo)

Inactivated (killed) vaccines

Example: Polio vaccine
Toxoid vaccines
Example: Tetanus, Diphtheria
Subunit vaccines
Antigenic parts isolated from pathogens
Common Animal Systems Used

Chick embryo
Mice
Rabbits
Horses
Monkeys
Examples
Rabies vaccine – chick embryo cell culture
Influenza vaccine – embryonated chicken eggs
Antisera – produced in horses

Animals in the Production of Pharmaceuticals


Animals are used to produce:
Hormones
Enzymes
Blood products
Antibodies
Examples
Product
Animal Source
Insulin (earlier)
Pig, Cow
Growth hormone
Animal pituitary
Antivenom
Horse
Blood clotting factors
Humanized animals
Antibodies
Mouse, Rabbit


Hybridoma Technology
Definition


Hybridoma technology is a method used to produce monoclonal antibodies by fusing antibody-producing B-lymphocytes with immortal myeloma cells.
Developed By
Georges Köhler and César Milstein (1975)
Nobel Prize – 1984

Steps in Hybridoma Technology

1. Immunization of Animal

Mouse is injected with a specific antigen.
B-cells in spleen produce antibodies.

2. Isolation of Spleen Cells

Antibody-producing B-lymphocytes are collected.

3. Fusion with Myeloma Cells

B-cells fused with cancerous myeloma cells using polyethylene glycol (PEG).
Forms hybridomas.

4. Selection of Hybridomas

Grown in HAT medium.
Only hybrid cells survive.

5. Screening

Hybridomas producing desired antibody are identified.

6. Cloning

Selected hybridomas cloned to obtain identical cells.

7. Large-scale Production

Cultured in bioreactors or injected into mice (ascites method).


Monoclonal Antibodies (mAbs)


Definition
Monoclonal antibodies are identical antibodies produced by a single clone of hybridoma cells and are specific to a single antigenic determinant (epitope).
Characteristics of Monoclonal Antibodies
Highly specific
Uniform in structure
Reproducible
Large-scale production possible


Applications of Monoclonal Antibodies


1. Medical Applications

Cancer diagnosis and therapy
Autoimmune diseases
Organ transplant rejection control
Targeted drug delivery

2. Diagnostic Uses

ELISA
Pregnancy test kits
Detection of pathogens

3. Research Applications

Identification of cell surface markers
Protein purification

4. Pharmaceutical Uses

Therapeutic antibodies (e.g., Rituximab, Trastuzumab)

Advantages of Animal-based Production
Proper protein folding
Post-translational modification
High biological activity
Limitations
Ethical concerns
Risk of contamination
High production cost
Immune reactions (HAMA response)


Conclusion
Animals play an indispensable role in the production of vaccines and pharmaceuticals. Hybridoma technology revolutionized antibody production, leading to the development of monoclonal antibodies with wide applications in medicine, diagnostics, and research. Despite limitations, advances in biotechnology continue to improve safety and efficiency.

50 MCQ  

1. Hybridoma technology was developed by
a) Watson and Crick
b) Paul Ehrlich
c) Köhler and Milstein
d) Jenner
✅ Answer: c
2. Hybridoma cells are formed by fusion of
a) T cells and B cells
b) B cells and myeloma cells
c) Myeloma and stem cells
d) Plasma cells and T cells
✅ Answer: b
3. Myeloma cells are
a) Normal B cells
b) Cancerous antibody-producing cells
c) Cancerous plasma cells
d) Stem cells
✅ Answer: c
4. PEG is used in hybridoma technology for
a) Cell culture
b) Screening
c) Cell fusion
d) Cloning
✅ Answer: c
5. HAT medium is used for
a) Fusion
b) Selection of hybridomas
c) Antibody purification
d) Immunization
✅ Answer: b
6. Monoclonal antibodies are
a) Different antibodies
b) Polyclonal antibodies
c) Identical antibodies
d) Mixed antibodies
✅ Answer: c
7. Source of B-lymphocytes in hybridoma technology
a) Liver
b) Bone marrow
c) Spleen
d) Thymus
✅ Answer: c
8. Animal commonly used in hybridoma technology
a) Rabbit
b) Mouse
c) Horse
d) Monkey
✅ Answer: b
9. Antigen is injected into which animal
a) Goat
b) Rat
c) Mouse
d) Horse
✅ Answer: c
10. Ascites method is used for
a) Vaccine production
b) Antibody purification
c) Large-scale mAb production
d) Screening
✅ Answer: c
11. Monoclonal antibodies recognize
a) Multiple epitopes
b) Single epitope
c) Whole antigen
d) Pathogen
✅ Answer: b
12. Polyclonal antibodies are produced by
a) Single B cell clone
b) Multiple B cell clones
c) Hybridoma cells
d) Myeloma cells
✅ Answer: b
13. ELISA uses
a) Enzymes
b) Antibodies
c) Antigens
d) All of the above
✅ Answer: d
14. Antivenom is produced in
a) Cow
b) Horse
c) Sheep
d) Mouse
✅ Answer: b
15. Influenza vaccine is produced using
a) Mouse cells
b) Bacterial cells
c) Chick embryo
d) Horse serum
✅ Answer: c
16. Rabies vaccine is produced in
a) Monkey kidney cells
b) Chick embryo
c) Human liver cells
d) Yeast cells
✅ Answer: b
17. Insulin was earlier extracted from
a) Sheep
b) Cow and pig
c) Mouse
d) Horse
✅ Answer: b
18. Toxoid vaccine example
a) Polio
b) Rabies
c) Tetanus
d) Measles
✅ Answer: c
19. Hybridomas are
a) Immortal cells
b) Short-lived cells
c) Dead cells
d) Stem cells
✅ Answer: a
20. Main advantage of monoclonal antibodies
a) Low specificity
b) High specificity
c) Low cost
d) Mixed response
✅ Answer: b
21. Myeloma cells lack ability to
a) Divide
b) Produce antibodies
c) Survive in culture
d) Fuse
✅ Answer: b
22. Nobel Prize for hybridoma technology was awarded in
a) 1975
b) 1980
c) 1984
d) 1990
✅ Answer: c
23. Pregnancy test kit works on
a) Antigen-antibody reaction
b) DNA hybridization
c) PCR
d) Cell fusion
✅ Answer: a
24. Monoclonal antibodies are used in
a) Cancer therapy
b) Diagnosis
c) Research
d) All of the above
✅ Answer: d
25. HAMA reaction occurs due to
a) Mouse antibodies in humans
b) Human antibodies in mice
c) Viral infection
d) Bacterial contamination
✅ Answer: a
26. Antibody-producing cells are
a) T lymphocytes
b) B lymphocytes
c) Macrophages
d) Neutrophils
✅ Answer: b
27. Which vaccine uses killed pathogen
a) Live vaccine
b) Inactivated vaccine
c) Subunit vaccine
d) Toxoid
✅ Answer: b
28. Monoclonal antibodies are uniform because they are produced from
a) Different cells
b) Same clone
c) Different antigens
d) Multiple species
✅ Answer: b
29. Cell fusion in hybridoma is chemical mediated by
a) Ethanol
b) PEG
c) Methanol
d) Acetone
✅ Answer: b
30. Animal used for antiserum production
a) Mouse
b) Horse
c) Rabbit
d) Monkey
✅ Answer: b
31. Diagnostic use of mAbs includes
a) Blood grouping
b) ELISA
c) Cancer markers
d) All
✅ Answer: d
32. Vaccine containing weakened pathogen
a) Killed
b) Toxoid
c) Live attenuated
d) Subunit
✅ Answer: c
33. Main limitation of animal-based pharmaceuticals
a) Ethical issues
b) High specificity
c) Easy availability
d) Low cost
✅ Answer: a
34. Hybridoma cells can be cultured
a) In vitro
b) In vivo
c) Both a and b
d) None
✅ Answer: c
35. Blood clotting factor VIII is used in
a) Diabetes
b) Hemophilia
c) Cancer
d) Malaria
✅ Answer: b
36. Subunit vaccines contain
a) Whole pathogen
b) Toxin
c) Antigenic part
d) DNA
✅ Answer: c
37. Primary host used in vaccine safety testing
a) Human
b) Animal
c) Plant
d) Microbe
✅ Answer: b
38. Hybridoma technology produces
a) Polyclonal antibodies
b) Monoclonal antibodies
c) Antigens
d) Vaccines
✅ Answer: b
39. Function of antibodies
a) Digestion
b) Immunity
c) Respiration
d) Excretion
✅ Answer: b
40. Which is NOT an application of monoclonal antibodies
a) Cancer therapy
b) Hormone production
c) Diagnosis
d) Research
✅ Answer: b
41. Antigen specificity of monoclonal antibodies is
a) Low
b) Moderate
c) High
d) Variable
✅ Answer: c
42. Ascitic fluid is rich in
a) Antigens
b) Antibodies
c) Hormones
d) Enzymes
✅ Answer: b
43. Vaccine against tetanus is
a) Live
b) Killed
c) Toxoid
d) Subunit
✅ Answer: c
44. Which animal is commonly used for polyclonal antibodies
a) Mouse
b) Rabbit
c) Horse
d) All
✅ Answer: d
45. Hybridoma cells are selected by
a) PEG
b) HAT medium
c) Antigen
d) Enzyme
✅ Answer: b
46. Monoclonal antibodies are used to identify
a) DNA
b) RNA
c) Cell surface markers
d) Lipids
✅ Answer: c
47. Production of vaccines requires
a) Animals
b) Microorganisms
c) Cell culture
d) All of the above
✅ Answer: d
48. First monoclonal antibody produced in
a) Human
b) Mouse
c) Rabbit
d) Horse
✅ Answer: b
49. Myeloma cells are
a) Mortal
b) Immortal
c) Dead
d) Differentiated
✅ Answer: b
50. Monoclonal antibodies are preferred because they are
a) Cheap
b) Non-specific
c) Highly specific
d) Unstable
✅ Answer: c



Comments

Post a Comment

Popular Posts

••CLASSIFICATION OF ALGAE - FRITSCH

      MODULE -1       PHYCOLOGY  CLASSIFICATION OF ALGAE - FRITSCH  ❖F.E. Fritsch (1935, 1945) in his book“The Structure and  Reproduction of the Algae”proposed a system of classification of  algae. He treated algae giving rank of division and divided it into 11  classes. His classification of algae is mainly based upon characters of  pigments, flagella and reserve food material.     Classification of Fritsch was based on the following criteria o Pigmentation. o Types of flagella  o Assimilatory products  o Thallus structure  o Method of reproduction          Fritsch divided algae into the following 11 classes  1. Chlorophyceae  2. Xanthophyceae  3. Chrysophyceae  4. Bacillariophyceae  5. Cryptophyceae  6. Dinophyceae  7. Chloromonadineae  8. Euglenineae    9. Phaeophyceae  10. Rhodophyceae  11. Myxophyce...
Post a Comment
Read more

Biological Databases – Types of Data and DatabasesNucleotide Sequence Databases (EMBL, GenBank, DDBJ)

Biological Databases – Types of Data and Databases Nucleotide Sequence Databases (EMBL, GenBank, DDBJ) 1. Introduction Biological databases are systematic, computerized collections of biological information that allow efficient storage, retrieval, updating, and analysis of large volumes of biological data. With the advent of genome sequencing, molecular biology, and bioinformatics, biological databases have become essential tools in biological research. These databases support studies in genomics, proteomics, evolutionary biology, taxonomy, medicine, agriculture, and biotechnology. 2. Types of Data Stored in Biological Databases Biological databases store diverse types of biological information, including: 1. Sequence Data DNA sequences RNA sequences Protein sequences 2. Structural Data Three-dimensional structures of proteins Nucleic acid structures 3. Functional Data Gene functions Enzyme activity Regulatory elements 4. Genomic Annotation Data Gene location Exons, introns Promoters a...
Post a Comment
Read more

Gene Transfer Technologies – Detailed Notes

Gene Transfer Technologies – Detailed Notes 1. Definition Gene transfer is the process of introducing foreign DNA or genes into the genome of a target organism or cell. It allows the expression of new traits, study of gene function, and production of therapeutic proteins. Also known as gene delivery or genetic transformation. 2. Principles of Gene Transfer Involves delivery of DNA or RNA into cells or organisms. DNA can be integrated into the host genome or remain episomal (non-integrated). The goal is stable or transient expression of the transferred gene. Key considerations: Vector – vehicle for carrying the gene Target cell – plant, animal, microbial, or human cells Delivery method – physical, chemical, or biological 3. Types of Gene Transfer Gene transfer can be broadly classified into: A. Natural Gene Transfer Occurs in nature between organisms: Transformation: Uptake of naked DNA by bacteria. Transduction: DNA transfer via viruses (bacteriophages). Conjugation: Transfer of plasmi...
Post a Comment
Read more

𓆞 Western Blotting Notes

Western Blotting (Immunoblotting) ❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥  Introduction Western blotting, also known as immunoblotting, is a widely used analytical technique for the detection, identification, and quantification of specific proteins in a complex biological sample. The technique combines protein separation by gel electrophoresis with specific antigen–antibody interaction. The method was developed by Towbin et al. (1979) (Burnette 1981---its group work) and is called “Western” in analogy to Southern blotting (DNA) and Northern blotting (RNA). Principle The principle of Western blotting involves: Separation of proteins based on molecular weight using SDS-PAGE Transfer (blotting) of separated proteins onto a membrane Specific detection of the target protein using primary and secondary antibodies Visualization using enzymatic or fluorescent detection systems 👉 Antigen–antibody specificity is the core principle of Western blotting. Steps Involved in Western Blotting 1. Sa...
Post a Comment
Read more

Microbial Production of PharmaceuticalsSomatostatin, Humulin and Interferons

Microbial Production of Pharmaceuticals Somatostatin, Humulin and Interferons 1. Introduction Advances in recombinant DNA technology have enabled microorganisms to produce human therapeutic proteins safely, economically and in large quantities. Microbial systems such as Escherichia coli and yeast (Saccharomyces cerevisiae) are widely used for the production of pharmaceuticals that were earlier isolated from human or animal tissues. Important microbial-derived pharmaceuticals include somatostatin, human insulin (Humulin) and interferons. 2. Advantages of Microbial Production of Pharmaceuticals High yield and rapid production Cost-effective and scalable Free from animal pathogens Consistent product quality Easy genetic manipulation 3. General Steps in Microbial Production of Recombinant Pharmaceuticals Isolation of target gene Construction of recombinant DNA Insertion into suitable vector Transformation into host microorganism Expression of protein Downstream processing and purification ...
Post a Comment
Read more

Molecular Marker Techniques

Molecular Marker Techniques (30-Mark Detailed Notes) Introduction Molecular markers are DNA sequences with known locations on chromosomes that can be used to identify individuals, genotypes, or genetic differences. They reveal polymorphism at the DNA level and are not influenced by environmental factors, unlike morphological or biochemical markers. Molecular marker techniques are widely used in genetics, plant breeding, biotechnology, forensics, medical diagnosis, and evolutionary studies. Characteristics of an Ideal Molecular Marker An ideal molecular marker should: Be highly polymorphic Show co-dominant inheritance Be abundant and uniformly distributed in the genome Be environment-independent Have high reproducibility Be easy, rapid, and cost-effective Classification of Molecular Marker    Techniques 1. Hybridization-Based Markers RFLP (Restriction Fragment Length Polymorphism) 2. PCR-Based Markers RAPD AFLP SSR (Microsatellites) ISSR 3. Sequence-Based Markers SNP (Single Nu...
Post a Comment
Read more

Direct Gene Transfer Using PEG

Direct Gene Transfer Using PEG Definition : Direct gene transfer using PEG is a chemical-mediated method to introduce foreign DNA into protoplasts (cells without cell walls) by promoting fusion of cell membranes, allowing the uptake of exogenous DNA. It is a widely used technique in plant genetic engineering and somatic hybridization. 1. Principle PEG is a polymer that induces aggregation and fusion of protoplast membranes. When protoplasts are incubated with foreign DNA in the presence of PEG, the DNA can enter the cytoplasm and nucleus. The method relies on membrane destabilization rather than a vector (virus, plasmid) for DNA delivery. Key Idea: PEG acts as a fusogen, bringing protoplasts or DNA into close contact with the cell membrane to facilitate uptake. 2. Materials Required Recipient protoplasts – plant or animal cells with cell walls removed. Donor DNA – plasmid, linear DNA, or genomic DNA. PEG solution – commonly PEG 4000–6000, at 20–50% (w/v) in water. Calcium ions (Ca²⁺) –...
Post a Comment
Read more

Gene Therapy – Detailed Notes

Gene Therapy – Detailed Notes Definition Gene therapy is a therapeutic technique in which genetic material (DNA or RNA) is introduced, removed, or modified in a patient’s cells to treat or prevent genetic disorders and diseases by correcting defective genes or providing new functional genes. Basic Concept Many diseases occur due to mutation, deletion, or malfunction of genes. Gene therapy aims to: Replace a defective gene Add a functional gene Silence or inhibit a harmful gene It works at the molecular level, targeting the root cause of disease rather than symptoms. Types of Gene Therapy 1. Somatic Gene Therapy Gene transfer into somatic (body) cells. Effects are not inherited. Most widely used and ethically accepted. Examples: Cystic fibrosis, cancer therapy, SCID 2. Germline Gene Therapy Gene transfer into germ cells (sperm/egg) or early embryos. Genetic changes are heritable. Ethically restricted and banned in many countries. Approaches of Gene Therapy 1. Gene Replacement Therapy De...
Post a Comment
Read more

Protein Structure Database (PDB)

Protein Structure Database (PDB) Introduction The Protein Structure Database (PDB) is the primary global repository for the three-dimensional (3D) structures of biological macromolecules such as proteins, nucleic acids, and protein–ligand complexes. These structures are determined experimentally using techniques like X-ray crystallography, Nuclear Magnetic Resonance (NMR) spectroscopy, and Cryo-Electron Microscopy (Cryo-EM). PDB plays a vital role in understanding: Protein structure and function Molecular interactions Drug discovery and design Structural biology and bioinformatics History and Development Established in 1971 Founded by Brookhaven National Laboratory (USA) Initially contained only 7 protein structures Now maintained by the Worldwide Protein Data Bank (wwPDB) Members of wwPDB RCSB PDB (USA) PDBe (Europe) PDBj (Japan) BMRB (Biological Magnetic Resonance Data Bank) Objectives of PDB To collect, store, and distribute 3D structural data of biomolecules To provide free and ope...
Post a Comment
Read more

RAPD (Random Amplified Polymorphic DNA)

RAPD (Random Amplified Polymorphic DNA) Introduction RAPD is a PCR-based molecular marker technique used to detect genetic variation at the DNA level. Developed by Williams et al., 1990. RAPD markers are dominant, randomly distributed, and do not require prior knowledge of DNA sequences. Commonly used in genetic diversity studies, plant breeding, population genetics, and phylogenetics. Principle RAPD relies on the amplification of random DNA segments using short arbitrary primers (usually 10 nucleotides). Polymorphism occurs due to: Presence or absence of primer binding sites Insertions or deletions in the DNA Point mutations in the primer sites Key idea : Random primers anneal to complementary sites → PCR amplification → Different band patterns between individuals → Polymorphism analysis Materials Required Genomic DNA Arbitrary oligonucleotide primers (10-mer) PCR reagents: Taq polymerase, dNTPs, buffer, Mg²⁺ Thermal cycler Agarose gel and electrophoresis equipment DNA staining dyes (...
Post a Comment
Read more